Raymond James Financial Services Advisors’s Cellectar Biosciences CLRB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	$64.2K	Hold	1,000	–	–	﹤0.01%	3327
2024 Q2	$75K	Hold	1,000	–	–	﹤0.01%	3264
2024 Q1	$119K	Buy	+1,000	New	+$119K	﹤0.01%	3194